Trade Puma Biotechnology, Inc. - PBYI stock price

9.9435
+0.02%
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States. Its drug candidates include PB272 neratinib (oral) for the treatment of early stage breast cancer, metastatic breast cancer, non-small cell lung cancer, HER2 mutation-positive solid tumors, and HER2-mutated non-amplified breast cancer; and PB272 neratinib (intravenous). The company also develops PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. It has a license agreement with Pfizer, Inc. for the development, manufacture, and commercialization of PB272 neratinib (oral), PB272 neratinib (intravenous), PB357, and certain related compounds. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.
White Paper Declaration

PBYI price history

Date Close Change Chg% Open Min. Max.
2022-09-30 9.5185 -0.0099 -0.10 9.5284 9.4094 9.5878
2022-09-30 9.5086 0.2384 2.57 9.2702 9.2305 9.578
2022-09-30 9.4294 0.2787 3.05 9.1507 9.1507 9.4987
2022-09-30 9.2908 0.2687 2.98 9.0221 9.0022 9.2908
2022-09-30 9.1718 0.1398 1.55 9.032 8.894 9.2908
2022-09-30 9.0728 0.1595 1.79 8.9133 8.8142 9.1222
2022-09-30 8.9936 -0.0291 -0.32 9.0227 8.8151 9.0725
2022-09-30 9.1025 0.2788 3.16 8.8237 8.7356 9.1125
2022-09-30 9.0035 -0.2364 -2.56 9.2399 8.9143 9.36
2022-09-30 9.3106 0.3866 4.33 8.924 8.7654 9.4789
2022-09-30 9.4294 0.1400 1.51 9.2894 9.1716 9.5384
2022-09-30 9.2809 -0.2163 -2.28 9.4972 9.2709 9.5677

Mobile app

Full trading account functionality: order execution and cancellation, stop-loss and take-profit setup, transaction history, deposits and withdrawals

iOS
4,7
12 127 reviews
Android
4,1
9 795 reviews
Go help.dzengi.com
Dzengi Exchange
Trade BTC & tokenized stocks